Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.
- Published In:
- EBioMedicine, 45, 630-645 (2019)
- Authors:
- Tsoumpra, Maria K, Fukumoto, Seiji, Matsumoto, Toshio, Takeda, Shin'ichi, Wood, Matthew J A, Aoki, Yoshitsugu
- Database ID:
- RPEP-04527
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04527APA
Tsoumpra, Maria K; Fukumoto, Seiji; Matsumoto, Toshio; Takeda, Shin'ichi; Wood, Matthew J A; Aoki, Yoshitsugu. (2019). Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.. EBioMedicine, 45, 630-645. https://doi.org/10.1016/j.ebiom.2019.06.036
MLA
Tsoumpra, Maria K, et al. "Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.." EBioMedicine, 2019. https://doi.org/10.1016/j.ebiom.2019.06.036
RethinkPeptides
RethinkPeptides Research Database. "Peptide-conjugate antisense based splice-correction for Duch..." RPEP-04527. Retrieved from https://rethinkpeptides.com/research/tsoumpra-2019-peptideconjugate-antisense-based-splicecorrection
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.